Fidelity Investments’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14K | Buy |
1,331
+338
| +34% | +$3.3K | ﹤0.01% | 4661 |
|
|
2025
Q4 | $11.4K | Buy |
993
+189
| +24% | +$2.92K | ﹤0.01% | 4679 |
|
|
2025
Q3 | $19.5K | Sell |
804
-497
| -38% | -$8.28K | ﹤0.01% | 4366 |
|
|
2025
Q2 | $21.4K | Buy |
1,301
+451
| +53% | +$7.79K | ﹤0.01% | 4258 |
|
|
2025
Q1 | $15.5K | Buy |
850
+697
| +456% | +$19.9K | ﹤0.01% | 4328 |
|
|
2024
Q4 | $5.68K | Buy |
153
+38
| +33% | +$1.45K | ﹤0.01% | 4639 |
|
|
2024
Q3 | $3.69K | Sell |
115
-72
| -39% | -$4K | ﹤0.01% | 4684 |
|
|
2024
Q2 | $15.3K | Sell |
187
-257
| -58% | -$27.8K | ﹤0.01% | 4171 |
|
|
2024
Q1 | $64.3K | Buy |
444
+261
| +143% | +$22K | ﹤0.01% | 3462 |
|
|
2023
Q4 | $16.9K | Sell |
183
-540
| -75% | -$54.9K | ﹤0.01% | 4033 |
|
|
2023
Q3 | $119K | Buy |
723
+92
| +15% | +$12K | ﹤0.01% | 3044 |
|
|
2023
Q2 | $39.9K | Buy |
631
+475
| +304% | +$28.8K | ﹤0.01% | 3545 |
|
|
2023
Q1 | $5.31K | Sell |
156
-159
| -50% | -$8.3K | ﹤0.01% | 4371 |
|
|
2022
Q4 | $18.2K | Sell |
315
-1,106
| -78% | -$68.3K | ﹤0.01% | 3812 |
|
|
2022
Q3 | $134K | Buy |
1,421
+1,278
| +894% | +$182K | ﹤0.01% | 3178 |
|
|
2022
Q2 | $32K | Buy |
143
+101
| +240% | +$33.8K | ﹤0.01% | 3720 |
|
|
2022
Q1 | $23K | Buy |
+42
| New | +$25.4K | ﹤0.01% | 3953 |
|
|
2021
Q4 | – | Sell |
-1
| Closed | -$1K | – | 4378 |
|
|
2021
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 4104 |
|
|
2021
Q2 | $1K | Sell |
1
-22,824
| -100% | -$25.8M | ﹤0.01% | 4004 |
|
|
2021
Q1 | $25M | Sell |
22,825
-9,904
| -30% | -$13.1M | ﹤0.01% | 1711 |
|
|
2020
Q4 | $46.7M | Buy |
32,729
+6,959
| +27% | +$7.42M | ﹤0.01% | 1349 |
|
|
2020
Q3 | $18.2M | Sell |
25,770
-145
| -0.6% | -$105K | ﹤0.01% | 1602 |
|
|
2020
Q2 | $18.1M | Sell |
25,915
-123,080
| -83% | -$71.1M | ﹤0.01% | 1591 |
|
|
2020
Q1 | $52.1M | Sell |
148,995
-236,681
| -61% | -$168M | 0.01% | 1015 |
|
|
2019
Q4 | $242M | Buy |
385,676
+20,763
| +6% | +$10.2M | 0.03% | 577 |
|
|
2019
Q3 | $122M | Buy |
364,913
+26,370
| +8% | +$8.45M | 0.01% | 809 |
|
|
2019
Q2 | $88M | Buy |
338,543
+10,086
| +3% | +$2.02M | 0.01% | 968 |
|
|
2019
Q1 | $54.3M | Buy |
328,457
+7,284
| +2% | +$1.18M | 0.01% | 1180 |
|
|
2018
Q4 | $34.8M | Buy |
321,173
+1,716
| +0.5% | +$289K | ﹤0.01% | 1321 |
|
|
2018
Q3 | $80M | Buy |
319,457
+130,037
| +69% | +$28M | 0.01% | 1046 |
|
|
2018
Q2 | $41.2M | Buy |
189,420
+45,983
| +32% | +$8.51M | ﹤0.01% | 1376 |
|
|
2018
Q1 | $21M | Buy |
+143,437
| New | +$24.3M | ﹤0.01% | 1705 |
|
Other funds holding CDLX
CIP
VCM
6CM
KGAMU
WPM
RC
QOP
Fidelity Investments's CDLX Position: Q1 2026 in Review
Fidelity Investments increased its Cardlytics (CDLX) stake by 34% in Q1 2026, buying an estimated $3.3K and bringing the position to 1,331 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #4661.
Fidelity Investments first reported a position in CDLX in Q1 2018 and has held it in 32 quarters since. The position peaked at $242M in Q4 2019. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.
- Fidelity Investments held 1,331 shares of Cardlytics worth $14K as of Q1 2026.
- Fidelity Investments bought 338 Cardlytics shares in Q1 2026, an estimated $3.3K.
- Cardlytics made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #4661 holding.
- Fidelity Investments first reported a position in Cardlytics in Q1 2018 and has held it in 32 quarters since.
- Fidelity Investments's Cardlytics position peaked at $242M in Q4 2019.
- 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.